Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company’s Tuesday update revealing the long‑term results from a cancer therapy study.
Moderna Stock Skyrockets To 52-Week High: What’s Behind The Surge?
view original post